US Patent 11186555 Methods and compositions for gamma-glutamyl cycle modulation
Patent 11186555 was granted and assigned to Cancer Research Technology Limited on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 17, 2019
Date of Patent
November 30, 2021
Patent Applicant
Patent Application Number
16443795
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11186555 Methods and compositions for gamma-glutamyl cycle modulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.